Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Osteocrin ,a Novel Predictive Bone-derived Humoral Factor,in Diabetes Mellitus, and Its Relation With Glycemic Control and Vascular Complications

NCT05719740 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05719740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05719740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Osteocrin ,a Novel Predictive Bone-derived Humoral Factor,in Diabetes Mellitus, and Its Relation With Glycemic Control and Vascular Complications
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2023
Completion date
February 28, 2025
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

whether osteocrin levels are associated with glycemic control, vascular disorders in diabetic patients